TY  - GEN
AU  - Oneyama,Masataka
AU  - Sakamoto,Naoya
AU  - Oue,Naohide
AU  - Kimura,Yayoi
AU  - Hiroshima,Yukihiko
AU  - Hashimoto,Itaru
AU  - Hara,Kentaro
AU  - Maezawa,Yukio
AU  - Kano,Kazuki
AU  - Aoyama,Toru
AU  - Fujikawa,Hirohito
AU  - Yamada,Takanobu
AU  - Tamagawa,Hiroshi
AU  - Yamamoto,Naoto
AU  - Ogata,Takashi
AU  - Cho,Haruhiko
AU  - Ito,Hiroyuki
AU  - Yukawa,Norio
AU  - Shiozawa,Manabu
AU  - Yoshikawa,Takaki
AU  - Morinaga,Soichiro
AU  - Rino,Yasushi
AU  - Masuda,Munetaka
AU  - Miyagi,Yohei
AU  - Yasui,Wataru
AU  - Oshima,Takashi
TI  - Clinical Significance of KIAA1199 as a Novel Target for Gastric Cancer Drug Therapy
SN  - 1791-7530
PY  - 2019///1213
KW  - Aged
KW  - Cell Line, Tumor
KW  - Cell Proliferation
KW  - Chemotherapy, Adjuvant
KW  - Digestive System Surgical Procedures
KW  - Drug Combinations
KW  - Female
KW  - Gene Expression Regulation, Neoplastic
KW  - Humans
KW  - Hyaluronoglucosaminidase
KW  - genetics
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Invasiveness
KW  - Oxonic Acid
KW  - therapeutic use
KW  - Prognosis
KW  - Stomach Neoplasms
KW  - Survival Analysis
KW  - Tegafur
KW  - Up-Regulation
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.21873/anticanres.13872
ER  -